DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Our Innovation Is Inspired by Patient Experience
At Ionis, our efforts begin and end with the patient in mind. From discovery to development to getting medicines into the hands of those who need it, we are inspired by the needs of the patient communities we serve, and fueled by the promise of our science. Every aspect of what we do is grounded in patient perspectives.
Take a closer look at some of the people who inspire our work.
Share

Related Content
-
educationPrevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisStudy Objectives: To assess prevalence,...
-
videos & visualsNovel Agents for the Treatment of AL Amyloidosis: Dr. Tibor Kovacsovics – ASG Webinar 3/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
people & placesStephen Heitner, MDStephen Heitner is a Senior Medical Dire...
-
educationAmyloidosis and its Management: Amyloid NeuropathiesThe amyloid neuropathies are rare, rapid...
-
news & meetingsFDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR AmyloidosisThe FDA today granted Alnylam Pharmaceut...
-
people & placesJeremy T. Larsen, MDJeremy T. Larsen is a Hematologist-Oncol...
-
educationTop 10 Things To Know When Performing Cardiac Imaging to Assess Cardiac AmyloidosisAmyloidoses are protein-folding disorder...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.